|
Market Closed -
TEL AVIV STOCK EXCHANGE
02:24:49 27/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 2,407.00 ILa | +0.42% |
|
+1.78% | +6.50% |
| 06/10 | Kamada Launches Ustekinumab, Enoxaparin Biosimilars in Israel | MT |
| 06/10 | Kamada Ltd. Announces Expansion of Biosimilars Portfolio with Launch of Two Additional Products in Israel | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KAMADA LTD. | Biopharmaceuticals | +0.42% | +1.78% | +6.50% | +6.46% | +33.65% | 450M |  |  |  |
- Stock Market
- Stocks
- KMDA Stock
- Charts Kamada Ltd.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
